Covered recipient · General Payments record
INDER P SINGH
Allopathic & Osteopathic Physicians Ophthalmology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2019 · Entire year
$329,831.87
404 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2019 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $110,397.50 | 63 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $69,065.00 | 31 |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $52,900.00 | 16 |
| Honoraria | $50,500.00 | 20 |
| Travel and Lodging | $37,441.96 | 92 |
| Food and Beverage | $9,527.41 | 182 |
By paying entity
PY2019 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Allergan Inc. | $83,660.71 | 128 |
| Bausch & Lomb, a division of Bausch Health US, LLC | $69,207.05 | 95 |
| Ellex, Inc | $58,296.52 | 35 |
| EllexiScience | $20,500.00 | 3 |
| Reichert, Inc. | $19,420.50 | 12 |
| Aerie Pharmaceuticals, Inc. | $15,782.90 | 30 |
| Glaukos Corporation | $14,362.37 | 15 |
| Sight Sciences, Inc. | $10,952.01 | 11 |
| Novartis Pharmaceuticals Corporation | $8,719.65 | 13 |
| Shire North American Group Inc | $8,596.28 | 8 |
| EyePoint Pharmaceuticals US, Inc. | $7,031.13 | 8 |
| Ivantis, Inc | $5,226.93 | 7 |
| Ocular Therapeutix, Inc. | $3,929.60 | 6 |
| NEW WORLD MEDICAL,INC. | $2,667.04 | 3 |
| Carl Zeiss Meditec, Inc. | $806.13 | 12 |
| Sun Pharmaceutical Industries Inc. | $182.46 | 4 |
| Alcon Vision LLC | $150.23 | 2 |
| Kala Pharmaceuticals, Inc. | $102.33 | 3 |
| THE CAMERON-EHLEN GROUP, INC. | $86.21 | 2 |
| Katena Products, Inc. | $51.60 | 1 |
| Eyevance Pharmaceuticals LLC | $37.75 | 3 |
| Omeros Corporation | $30.00 | 1 |
| Janssen Pharmaceuticals, Inc | $17.40 | 1 |
| Dompe US, Inc. | $15.07 | 1 |
Page 2 of 9; records 51–100 of 404 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
INDER P SINGH
NPI 1063430023 · CMS profile ID 139518
Allopathic & Osteopathic Physicians / Ophthalmology
RACINE, WI
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 2 of 9; records 51–100 of 404 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1063430023?year=2019&recipient=provider&page=2#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- INDER P SINGH, NPI 1063430023, CMS profile ID 139518. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 9; records 51–100 of 404 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1063430023?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
- APA 7
- IndustryPayments. (2026). INDER P SINGH, NPI 1063430023, CMS profile ID 139518. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 9; records 51–100 of 404 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1063430023?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
- Bluebook
- INDER P SINGH, NPI 1063430023, CMS profile ID 139518, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 9; records 51–100 of 404 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1063430023?year=2019&recipient=provider&page=2#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2019
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30
404 matching records · $329,831.87 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 51–100 of 404.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Ellex, Inc | $1,500.00 | 11/02/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 661983829 | CMS |
| Ellex, Inc | $1,380.00 | 11/01/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 661983805 | CMS |
| Sight Sciences, Inc. | $2,000.00 | 10/30/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 699800253 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $3,000.00 | 10/28/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 698071575 | CMS |
| NEW WORLD MEDICAL,INC. | $2,500.00 | 10/24/2019 | Honoraria | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 704138271 | CMS |
| Sight Sciences, Inc. | $2,000.00 | 10/23/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 699800249 | CMS |
| Allergan Inc. | $13.00 | 10/16/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671152061 | CMS |
| Ellex, Inc | $1,740.92 | 10/15/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 661983839 | CMS |
| Allergan Inc. | $2,750.00 | 10/13/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671152057 | CMS |
| Carl Zeiss Meditec, Inc. | $105.00 | 10/13/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 693204165 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $114.21 | 10/13/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 698071577 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $58.91 | 10/13/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 698071579 | CMS |
| Allergan Inc. | $2,750.00 | 10/12/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671152049 | CMS |
| Allergan Inc. | $500.00 | 10/12/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671152051 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $2,100.00 | 10/11/2019 | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492927 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $83.52 | 10/11/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492929 | CMS |
| Ivantis, Inc | $105.25 | 10/10/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 699823049 | CMS |
| Glaukos Corporation | $1,000.00 | 10/09/2019 | Honoraria | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 706934409 | CMS |
| Allergan Inc. | $323.60 | 10/07/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671152041 | CMS |
| Allergan Inc. | $2,750.00 | 10/07/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671152043 | CMS |
| Allergan Inc. | $124.99 | 10/07/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671152045 | CMS |
| Allergan Inc. | $127.95 | 10/07/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671152047 | CMS |
| Aerie Pharmaceuticals, Inc. | $122.92 | 10/04/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 662036901 | CMS |
| Sight Sciences, Inc. | $66.21 | 10/04/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 699800269 | CMS |
| THE CAMERON-EHLEN GROUP, INC. | $46.65 | 10/04/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 634697045 | CMS |
| Allergan Inc. | $1.86 | 10/02/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671152039 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $35.66 | 10/02/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492925 | CMS |
| Allergan Inc. | $2,750.00 | 10/01/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671152015 | CMS |
| Allergan Inc. | $124.98 | 10/01/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671152023 | CMS |
| Ellex, Inc | $1,380.00 | 10/01/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 661983803 | CMS |
| Ellex, Inc | $1,500.00 | 10/01/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 661983827 | CMS |
| Reichert, Inc. | $1,000.00 | 10/01/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 623745937 | CMS |
| Glaukos Corporation | $500.00 | 09/27/2019 | Honoraria | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 706934085 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $99.96 | 09/26/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492923 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $18.91 | 09/23/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492921 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $3,800.00 | 09/20/2019 | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492919 | CMS |
| Aerie Pharmaceuticals, Inc. | $2,450.00 | 09/19/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 662036925 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $193.05 | 09/19/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492917 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $133.62 | 09/18/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492911 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $3,800.00 | 09/18/2019 | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492913 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $2,100.00 | 09/18/2019 | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492915 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $228.00 | 09/17/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492909 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $1,220.00 | 09/16/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492905 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $610.00 | 09/16/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492907 | CMS |
| Allergan Inc. | $18.75 | 09/15/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671152009 | CMS |
| Allergan Inc. | $1,000.00 | 09/15/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671152011 | CMS |
| Sight Sciences, Inc. | $66.20 | 09/15/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 699800273 | CMS |
| Allergan Inc. | $3.16 | 09/11/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 671152005 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $3,800.00 | 09/11/2019 | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492901 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $102.19 | 09/11/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684492903 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Recipient | $74,550.50 | 8 |
| PY2025 | Principal investigator | $76,025.32 | 43 |
| PY2024 | Recipient | $60,858.50 | 5 |
| PY2024 | Principal investigator | $228,186.28 | 82 |
| PY2023 | Recipient | $21,927.50 | 10 |
| PY2023 | Principal investigator | $111,558.22 | 69 |
| PY2022 | Recipient | $12,243.00 | 2 |
| PY2022 | Principal investigator | $79,641.45 | 36 |
| PY2021 | Principal investigator | $109,297.02 | 38 |
| PY2020 | Recipient | $10,850.57 | 4 |
| PY2020 | Principal investigator | $102,666.86 | 54 |
| PY2019 | Principal investigator | $200,482.11 | 87 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
51 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | Glaukos Corporation | $10,415.00 | 12/10/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intracameral implant) in Conjunction with Cataract Surgery vs. Cataract Surgery Alone | No dispute reported | 06/30/2026 | 1250907442 |
| Principal investigator 1 | Alcon Research LLC | $554.50 | 11/19/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915474 |
| Principal investigator 1 | Glaukos Corporation | $505.00 | 11/19/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250907420 |
| Principal investigator 1 | Glaukos Corporation | $1,100.00 | 11/19/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intracameral implant) in Conjunction with Cataract Surgery vs. Cataract Surgery Alone | No dispute reported | 06/30/2026 | 1250907438 |
| Principal investigator 1 | Rayner Intraocular Lenses Limited | $345.00 | 11/17/2025 | Non-covered Recipient Entity ADVARRA INC | Not supplied | No dispute reported | 06/30/2026 | 1211224365 |
| Principal investigator 1 | Alcon Research LLC | $756.00 | 11/05/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915470 |
| Principal investigator 1 | Alcon Research LLC | $756.00 | 11/05/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915472 |
| Principal investigator 1 | Alcon Research LLC | $756.00 | 10/30/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915468 |
| Principal investigator 1 | Alcon Research LLC | $681.00 | 10/23/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915466 |
| Recipient | NEW WORLD MEDICAL,INC. | $1,380.00 | 10/23/2025 | Covered Recipient Physician | Streamline Venice Study | No dispute reported | 06/30/2026 | 1246944253 |
| Principal investigator 1 | Glaukos Corporation | $790.00 | 10/08/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250907416 |
| Principal investigator 1 | Glaukos Corporation | $7,925.00 | 10/08/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intracameral implant) in Conjunction with Cataract Surgery vs. Cataract Surgery Alone | No dispute reported | 06/30/2026 | 1250907432 |
| Principal investigator 1 | Glaukos Corporation | $1,240.00 | 10/08/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intracameral implant) in Conjunction with Cataract Surgery vs. Cataract Surgery Alone | No dispute reported | 06/30/2026 | 1250907435 |
| Principal investigator 1 | Glaukos Corporation | $570.00 | 09/10/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250907412 |
| Principal investigator 1 | Alcon Research LLC | $756.00 | 09/03/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915458 |
| Recipient | NEW WORLD MEDICAL,INC. | $444.00 | 09/02/2025 | Covered Recipient Physician | Streamline Venice Study | No dispute reported | 06/30/2026 | 1246944260 |
| Principal investigator 1 | Alcon Research LLC | $1,513.03 | 08/27/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915456 |
| Principal investigator 1 | Glaukos Corporation | $285.00 | 08/06/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250907407 |
| Principal investigator 1 | Alcon Research LLC | $681.00 | 07/23/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915482 |
| Principal investigator 1 | Alcon Research LLC | $1,513.03 | 07/16/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915476 |
| Recipient | NEW WORLD MEDICAL,INC. | $1,728.00 | 07/09/2025 | Covered Recipient Physician | Streamline Venice Study | No dispute reported | 06/30/2026 | 1246944265 |
| Principal investigator 1 | Glaukos Corporation | $430.00 | 07/02/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250907403 |
| Principal investigator 1 | Glaukos Corporation | $555.00 | 07/02/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intracameral implant) in Conjunction with Cataract Surgery vs. Cataract Surgery Alone | No dispute reported | 06/30/2026 | 1250907428 |
| Recipient | Ocular Therapeutix, Inc. | $1,000.00 | 06/30/2025 | Covered Recipient Physician | A prospective, multi-center, randomized, parallel-group, controlled study to evaluate the efficacy and safety of OTX-TIC (travoprost) intracameral implant in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT) | No dispute reported | 06/30/2026 | 1250229275 |
| Principal investigator 1 | Glaukos Corporation | $405.00 | 06/18/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250907395 |
| Principal investigator 1 | Glaukos Corporation | $517.24 | 06/04/2025 | Non-covered Recipient Entity Greenphire, Inc. | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250903696 |
| Principal investigator 1 | Alcon Research LLC | $646.50 | 05/21/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915378 |
| Principal investigator 1 | Alcon Research LLC | $681.00 | 05/14/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915376 |
| Recipient | NEW WORLD MEDICAL,INC. | $1,824.00 | 05/14/2025 | Covered Recipient Physician | Streamline Venice Study | No dispute reported | 06/30/2026 | 1246944242 |
| Principal investigator 1 | Alcon Research LLC | $554.50 | 05/07/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915374 |
| Principal investigator 1 | Glaukos Corporation | $430.00 | 05/07/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250907400 |
| Principal investigator 1 | Glaukos Corporation | $22,485.00 | 05/07/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intracameral implant) in Conjunction with Cataract Surgery vs. Cataract Surgery Alone | No dispute reported | 06/30/2026 | 1250907424 |
| Principal investigator 1 | Alcon Research LLC | $554.50 | 04/16/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915372 |
| Principal investigator 1 | Alcon Research LLC | $646.50 | 04/09/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915370 |
| Recipient | NEW WORLD MEDICAL,INC. | $11,352.00 | 04/09/2025 | Covered Recipient Physician | Streamline Venice Study | No dispute reported | 06/30/2026 | 1246944250 |
| Principal investigator 1 | ABBVIE INC. | $10,093.00 | 04/03/2025 | Non-covered Recipient Entity EYE CENTER OF RACINE & KENOSHA LTD | A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma | No dispute reported | 06/30/2026 | 1202469683 |
| Principal investigator 1 | Glaukos Corporation | $517.24 | 04/02/2025 | Non-covered Recipient Entity Greenphire, Inc. | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250904642 |
| Principal investigator 1 | Glaukos Corporation | $258.62 | 03/12/2025 | Non-covered Recipient Entity Greenphire, Inc. | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250904530 |
| Principal investigator 1 | Alcon Research LLC | $554.50 | 03/05/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915508 |
| Principal investigator 1 | Alcon Research LLC | $554.50 | 03/05/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915510 |
| Recipient | ABBVIE INC. | $70.00 | 02/28/2025 | Covered Recipient Physician | A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma | No dispute reported | 06/30/2026 | 1202401352 |
| Principal investigator 1 | Alcon Research LLC | $587.00 | 02/27/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915506 |
| Principal investigator 1 | Glaukos Corporation | $258.62 | 02/19/2025 | Non-covered Recipient Entity Greenphire, Inc. | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250905020 |
| Principal investigator 1 | Glaukos Corporation | $421.30 | 02/19/2025 | Non-covered Recipient Entity Commercial Print Management | Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intracameral implant) in Conjunction with Cataract Surgery vs. Cataract Surgery Alone | No dispute reported | 06/30/2026 | 1250907888 |
| Principal investigator 1 | Glaukos Corporation | $105.00 | 02/12/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250907391 |
| Principal investigator 1 | Alcon Research LLC | $646.50 | 01/30/2025 | Non-covered Recipient Entity EYE CENTERS OF RACINE AND KENOSHA | The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial | No dispute reported | 06/30/2026 | 1220915504 |
| Principal investigator 1 | Glaukos Corporation | $258.62 | 01/29/2025 | Non-covered Recipient Entity Greenphire, Inc. | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250904908 |
| Recipient | Rayner Intraocular Lenses Limited | $56,752.50 | 01/21/2025 | Covered Recipient Physician | Not supplied | No dispute reported | 06/30/2026 | 1211224353 |
| Principal investigator 1 | Rayner Intraocular Lenses Limited | $1,280.00 | 01/21/2025 | Non-covered Recipient Entity ADVARRA INC | Not supplied | No dispute reported | 06/30/2026 | 1211224355 |
| Principal investigator 1 | Glaukos Corporation | $258.62 | 01/08/2025 | Non-covered Recipient Entity Greenphire, Inc. | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250905594 |
| Principal investigator 1 | Glaukos Corporation | $1,185.00 | 01/08/2025 | Non-covered Recipient Entity Eye Center of Racine & Kenosha | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension | No dispute reported | 06/30/2026 | 1250907387 |